<p>Values are means ± SE (n = 8) MAP : mean arterial pressure, HR : heart rate, LVSP : left ventricular systolic pressure, LVEDP : left ventricular end-diastolic pressure, DP : development pressure, +dP/dt and −dP/dt : maximal slope of the systolic pressure increment and diastolic pressure decrement, respectively, Ves : end-systolic volume, Ved : end-diastolic volume, SV : stroke volume, EF : ejection fraction, ESPVR : end-systolic pressure–volume relation, and EDPVR : end-diastolic pressure–volume relation.</p><p>p<0.05 vs. wild-type 6 week sham,</p><p><sup>#</sup> p<0.05 vs. wild-type 6 week AAB,</p><p><sup>@</sup> p<0.05 vs. wild-type 10 week sham,</p><p><sup>&</sup> p<0.05 vs. wild-type 10 week AAB,</p><p>p<0.05 vs. DPP4 deficiency 6 we...
<p>Values are means ± SEM and range; n = 6 rats/group. BW, body weight.</p>*<p>indicates a statistic...
<p>Hemodynamic Parameters obtained from rats treated with AAV9.I-1c at 3 months after aortic banding...
<p>Grouped data (mean ± SEM; n≥7 per group) taken 21 days following injury by cardiac catheterizatio...
<p>HW: heart weight; BW: body weight; MAP: mean arterial pressure; LV: left ventricle; LVSP: left ve...
<p>Representative pressure-volume loops from a vehicle-treated (A) and an atorvastatin-treated (B) r...
<p>Values are means ± SE; n = 8 for all groups. S-Sham, sedentary sham rats; T-Sham, training sham r...
<p>*P<0.05 compared with Wistar control rats.</p><p>HR: heart rate, MAP: mean arterial pressure, LVS...
<p>Plasma DPP4 activity (A), plasma GLP-1 concentration (B), and plasma Ang II level (C) were measur...
<p>MBP, mean arterial blood pressure; HR, heart rate; LVP, left ventricular systolic pressure; LVEDP...
<p>LV, left ventricle;+LV dP/dtmax, maximum of the first differentiation of LV pressure. Values are ...
<p>Invasive blood pressure measurements were obtained on anesthetized rats during vascular phenotypi...
Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like p...
<p>Values are expressed as mean±SEM. In each group, values in <i>parentheses</i> represent <i>n</i>....
Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like p...
<p>LVEDP: left ventricular end-diastolic pressure; +LVdp/dtmax: maximum a positive rate of developed...
<p>Values are means ± SEM and range; n = 6 rats/group. BW, body weight.</p>*<p>indicates a statistic...
<p>Hemodynamic Parameters obtained from rats treated with AAV9.I-1c at 3 months after aortic banding...
<p>Grouped data (mean ± SEM; n≥7 per group) taken 21 days following injury by cardiac catheterizatio...
<p>HW: heart weight; BW: body weight; MAP: mean arterial pressure; LV: left ventricle; LVSP: left ve...
<p>Representative pressure-volume loops from a vehicle-treated (A) and an atorvastatin-treated (B) r...
<p>Values are means ± SE; n = 8 for all groups. S-Sham, sedentary sham rats; T-Sham, training sham r...
<p>*P<0.05 compared with Wistar control rats.</p><p>HR: heart rate, MAP: mean arterial pressure, LVS...
<p>Plasma DPP4 activity (A), plasma GLP-1 concentration (B), and plasma Ang II level (C) were measur...
<p>MBP, mean arterial blood pressure; HR, heart rate; LVP, left ventricular systolic pressure; LVEDP...
<p>LV, left ventricle;+LV dP/dtmax, maximum of the first differentiation of LV pressure. Values are ...
<p>Invasive blood pressure measurements were obtained on anesthetized rats during vascular phenotypi...
Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like p...
<p>Values are expressed as mean±SEM. In each group, values in <i>parentheses</i> represent <i>n</i>....
Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like p...
<p>LVEDP: left ventricular end-diastolic pressure; +LVdp/dtmax: maximum a positive rate of developed...
<p>Values are means ± SEM and range; n = 6 rats/group. BW, body weight.</p>*<p>indicates a statistic...
<p>Hemodynamic Parameters obtained from rats treated with AAV9.I-1c at 3 months after aortic banding...
<p>Grouped data (mean ± SEM; n≥7 per group) taken 21 days following injury by cardiac catheterizatio...